Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer

Identifying locoregional gastric cancer patients who are at high risk for relapse after resection could facilitate early intervention. By detecting molecular residual disease (MRD), circulating tumor DNA (ctDNA) has been shown to predict post-operative relapse in several cancers. Here, we aim to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jian, Gong, Yuhua, Lam, Vincent K., Shi, Yan, Guan, Yanfang, Zhang, Yanyan, Ji, Liyan, Chen, Yongsheng, Zhao, Yongliang, Qian, Feng, Chen, Jun, Li, Pingang, Zhang, Fan, Wang, Jiayin, Zhang, Xuanping, Yang, Ling, Kopetz, Scott, Futreal, P. Andrew, Zhang, Jianjun, Yi, Xin, Xia, Xuefeng, Yu, Peiwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214415/
https://www.ncbi.nlm.nih.gov/pubmed/32393783
http://dx.doi.org/10.1038/s41419-020-2531-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214415/
https://www.ncbi.nlm.nih.gov/pubmed/32393783
http://dx.doi.org/10.1038/s41419-020-2531-z

Ejemplares similares